Brief: Interpace Biosciences Q1 Revenue USD 11.515 Million
08/05/2025 21:05
May 08 (Reuters) - Interpace Biosciences Q1 gross profit USD 7.37 million. Q1 operating expenses USD 5.541 million Q1 operating income USD 1.829 million Q1 net income USD 1.647 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million